Immunotherapy employs patients' own immune systems to fight cancer, and it has shown itself to be an effective treatment in ...

In August 2025, Biocad conducted a study the efficacy, safety, pharmacokinetics and immunogenicity of BCD-236 in combination ...

AstraZeneca, in collaboration with Daiichi Sankyo, is conducting a Phase III clinical study titled A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator’s Choice of ...

Triple-negative breast cancer can be challenging to treat, in part because the disease spreads and grows faster than other forms of breast cancer, and in part because some of the treatment options ...

Unlike other breast cancers, TNBC tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein – the “triple negative” result that gives the cancer its name.

LE: If a breast cancer doesn’t express receptors for estrogen, progesterone, or HER2, the cancer is considered triple-negative. EH: Can you spell out for us why these biomarkers are so important?

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s prostate cancer was recently labelled “aggressive” and described as having ...

Spanish researchers have achieved a significant breakthrough in the fight against the deadliest form of breast cancer—triple-negative breast cancer (TNBC). This aggressive subtype is notorious for ...

Once they both got the diagnosis— the same exact diagnosis— the sisters decided to document their journey on social media to spread awareness.

Triple-negative breast cancer is more common in young women, and those diagnosed with breast cancer under the age of 40 are twice as likely to have TNBC than those between the ages of 50 and 64.

Triple-negative breast cancer is the most deadly form of the disease. This form of breast cancer has a disproportionate impact on women who are younger, African American or Hispanic, but new ...